Here, we showed that PTEN loss can potentially be used to predict the response of PC patients to radiotherapy (Fig. 6D), though multivariate analysis indicates that it may not be an independent predictive marker (Fig. 6E). This evidence concerns the gene PTEN and pachyonychia congenita.